Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00820495 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users
A Phase 2 study of Tobacco Use Disorder, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,683
- Enrollment target
- 2
- Study locations
NCT00820495 is a Phase 2 study of Tobacco Use Disorder that has completed, run by Oregon Research Institute. The registered enrollment target is 1,683 participants, above the 215-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (683% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT00820495, a Phase 2 study of Tobacco Use Disorder, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,683 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this record is to test whether (a) participants who receive a Web-based smokeless tobacco cessation intervention will be more likely to be abstinent than participants who do not receive this intervention, and (b) whether participants who receive a telephone quitline intervention will be more likely to be abstinent than participants who are not in a quitline intervention.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Web + Phone
- BEHAVIORAL Web Only
- BEHAVIORAL Phone Only
Study Locations (2)
California
- University of California, San Diego - San Diego
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,683 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00820495
The ClinicalTrials.gov registry entry for NCT00820495 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,683 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 215-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (683% higher). The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.
NCT00820495 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Oregon.
Frequently Asked Questions
What is clinical trial NCT00820495 about?
NCT00820495 is a clinical study titled "Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users". The purpose of this record is to test whether (a) participants who receive a Web-based smokeless tobacco cessation intervention will be more likely to be abstinent than participants who do not receive this intervention, and (b) whether participants who receive a telephone quitline intervention will ...
What is the current status of trial NCT00820495?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,683 participants. The study started on 2009-05. Estimated completion is 2012-05.
What conditions does trial NCT00820495 study?
This clinical trial studies the following conditions: Tobacco Use Disorder.
What interventions are being tested in trial NCT00820495?
The interventions under investigation include: Usual Care (BEHAVIORAL), Web + Phone (BEHAVIORAL), Web Only (BEHAVIORAL), Phone Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT00820495?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00820495 being conducted?
This trial has 2 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
RECRUITING · Phase 2
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
RECRUITING · Phase 2
-
Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.